Top Qs
Timeline
Chat
Perspective
DMBMPP
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
DMBMPP, or 2-(2,5-dimethoxy-4-bromobenzyl)-6-(2-methoxyphenyl)piperidine, also known as juncosamine, is a highly selective serotonin 5-HT2A receptor agonist and 2-benzylpiperidine analogue of the serotonergic psychedelic 25B-NBOMe that was discovered in 2011 by Jose Juncosa in the group of David E. Nichols at Purdue University.[1][2] It differs from 25B-NBOMe by incorporating the amine within a piperidine ring, making for a more rigid molecular structure than that of the open-chain 25B-NBOMe. The presence of the piperidine ring introduces two stereocenters, thus, four stereoisomers of this compound can be made.
Remove ads
Despite its uniquely high selectivity for the serotonin 5-HT2A receptor, it has been said that DMBMPP is not widely used as a pharmacological tool in scientific research, presumably due to its chemical synthesis being relatively inaccessible.[3] Consequently, 25CN-NBOH, another highly selective serotonin 5-HT2A receptor agonist, has been proposed as an alternative to DMBMPP for use in scientific research.[3]
Remove ads
Pharmacology
The (S,S)-isomer ((2S,6S)-DMBMPP) is the most selective agonist for the human serotonin 5-HT2A receptor yet discovered, with a Ki of 2.5 nM at the human 5-HT2A receptor and with 124-fold selectivity for the serotonin 5-HT2A receptor over the structurally similar serotonin 5-HT2C receptor.[2] Together with 25CN-NBOH,[4] (2S,6S)-DMBMPP is the only known 5-HT2A agonist to exhibit this level of selectivity.[3]
Remove ads
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads